Senescence: the good the bad and the dysfunctional

Current Opinion in Genetics and Development

Volumn 18, Issue 1, 2008, Pages 42-47

  Pazolli, Ermira ^a   Stewart, Sheila A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CANCER INHIBITION; CELL AGING; CELL CYCLE ARREST; CELL GROWTH; CELL STRESS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

CELL AGING; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 43749118949     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2007.12.002     Document Type: Review

References (41)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37 (1965) 614-636. The author demonstrates, for the first time, that normal human cells have limited replicative lifespan.
2. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 25 (1961) 585-621. Seminal paper challenging the dogma that normal human cells possess an infinite lifespan; the first demonstration of senescence in vitro.
3. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92 (1995) 9363-9367. The paper describes the discovery of the widely used senescence-associated marker SA-βgal, facilitating the identification of senescent cells in vitro and in vivo.
4. Campisi J., and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8 (2007) 729-740
5. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
6. Herbig U., Jobling W.A., Chen B.P., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14 (2004) 501-513
7. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P.G., Bensimon A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 (2006) 638-642. The authors demonstrate that oncogene-induced senescence is triggered by a DNA damage response induced by DNA hyperreplication.
8. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
9. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 13 (2003) 1549-1556
10. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006) 633-637. The authors demonstrate that oncogene-induced senescence is triggered by a DNA damage response induced by DNA hyperreplication.
11. Meier A., Fiegler H., Munoz P., Ellis P., Rigler D., Langford C., Blasco M.A., Carter N., and Jackson S.P. Spreading of mammalian DNA-damage response factors studied by ChIP-chip at damaged telomeres. EMBO J 26 (2007) 2707-2718
12. Won J., Kim M., Kim N., Ahn J.H., Lee W.G., Kim S.S., Chang K.Y., Yi Y.W., and Kim T.K. Small molecule-based reversible reprogramming of cellular lifespan. Nat Chem Biol 2 (2006) 369-374
13. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460. This paper describes the first evidence that replicative senescence is triggered by telomere shortening.
14. Campisi J. Suppressing cancer: the importance of being senescent. Science 309 (2005) 886-887
15. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 332 (1998) 43-50
16. Dimri G.P., Itahana K., Acosta M., and Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol 20 (2000) 273-285
17. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., and Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274 (1999) 7936-7940
18. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16ink4a. Cell 88 (1997) 593-602
19. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
20. Shay J.W., Pereira-Smith O.M., and Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196 (1991) 33-39
21. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., and Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724. The authors demonstrate that senescence acts as a tumor suppressor in vivo in human cells.
22. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., et al. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) p. 642.6. This paper demonstrates that oncogene expression induces senescence in vivo, which needs to be bypassed for malignant progression. The authors also identify four novel oncogene-induced senescence markers.
23. Sarkisian C.J., Keister B.A., Stairs D.B., Boxer R.B., Moody S.E., and Chodosh L.A. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9 (2007) 493-505
24. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730. This manuscript demonstrates that acute loss of a tumor suppressor induces p53-mediated senescence, thus inhibiting transformation.
25. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665. The authors demonstrate that establishment of oncogene-induced heterochromatic regions results in senescence and inhibition of tumor formation. Loss of the methlytransferase, SUV39H1 results in failure to establish heterochromatic regions in response to oncogene activation and tumor formation.
26. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660. The authors demonstrate that the restoration of p53 expression in tumors induces senescence and tumor regression in a murine liver model.
27. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., Newman J., Reczek E.E., Weissleder R., and Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 445 (2007) 661-665. This paper demonstrates that the restoration of p53 expression in tumors can induce apoptosis in lymphomas and senescence in sarcomas.
28. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
29. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., and Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 101 (2004) 4966-4971
30. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., and Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59 (1999) 5002-5011
31. Trougakos I.P., Saridaki A., Panayotou G., and Gonos E.S. Identification of differentially expressed proteins in senescent human embryonic fibroblasts. Mech Ageing Dev 127 (2006) 88-92
32. Bavik C., Coleman I., Dean J.P., Knudsen B., Plymate S., and Nelson P.S. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66 (2006) 794-802
33. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 98 (2001) 12072-12077. The authors provide the first evidence that demonstrates that senescent fibroblasts promote initiated epithelial growth and tumor formation.
34. Jeyapalan J.C., Ferreira M., Sedivy J.M., and Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128 (2007) 36-44
35. DePinho R.A. The age of cancer. Nature 408 (2000) 248-254
36. Parrinello S., Coppe J.P., Krtolica A., and Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118 (2005) 485-496
37. Coppe J.P., Kauser K., Campisi J., and Beausejour C.M. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 281 (2006) 29568-29574
38. Yang G., Rosen D.G., Zhang Z., Bast Jr. R.C., Mills G.B., Colacino J.A., Mercado-Uribe I., and Liu J. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U S A 103 (2006) 16472-16477
39. Vasile E., Tomita Y., Brown L.F., Kocher O., and Dvorak H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 15 (2001) 458-466
40. Kandel R., Li S.Q., Ozcelik H., and Rohan T. p53 protein accumulation and mutations in normal and benign breast tissue. Int J Cancer 87 (2000) 73-78
41. Larson P.S., de las Morenas A., Cupples L.A., Huang K., and Rosenberg C.L. Genetically abnormal clones in histologically normal breast tissue. Am J Pathol 152 (1998) 1591-1598